Health knowledge made personal
Join this community!
› Share page:
Search posts:

December 27, 2007 — The US ...

Posted Nov 10 2008 4:21pm

December 27, 2007 — The US Food and Drug Administration (FDA) has approved sapropterin dihydrochloride tablets for the adjunctive treatment of phenylketonuria, pantoprazole sodium delayed-release oral suspension for patients with gastroesophageal reflux disease unable to swallow tablets, and low-dose lopinavir/ritonavir 100-mg/25-mg tablets for use with other antiretroviral agents in the treatment of children with HIV infection.

FDA Approvals: Kuvan, Protonix, Kaletra

Post a comment
Write a comment: